These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6228349)

  • 1. Suppressor cell activity and phenotypes in the blood or tissues of patients with leprosy.
    Rea TH
    Clin Exp Immunol; 1983 Nov; 54(2):298-304. PubMed ID: 6228349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ characterization of T lymphocyte subsets in the reactional states of leprosy.
    Modlin RL; Gebhard JF; Taylor CR; Rea TH
    Clin Exp Immunol; 1983 Jul; 53(1):17-24. PubMed ID: 6223731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
    Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
    Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions.
    Shen JY; Hofman FM; Gunter JR; Modlin RL; Rea TH
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
    Laal S; Mishra RS; Nath I
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum.
    Modlin RL; Bakke AC; Vaccaro SA; Horwitz DA; Taylor CR; Rea TH
    Arch Dermatol; 1985 Feb; 121(2):216-9. PubMed ID: 3156560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A follow up of T-cell subsets and of anti-M. leprae antibody titer as measured by the FLA-ABS test in Melanesian leprosy patients under polychemotherapy.
    Garraud O; Ribierre O; Bach MA
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):38-45. PubMed ID: 2940306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis.
    Modlin RL; Hofman FM; Meyer PR; Sharma OP; Taylor CR; Rea TH
    Clin Exp Immunol; 1983 Mar; 51(3):430-8. PubMed ID: 6221839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalances in T cell subpopulations in lepromatous leprosy.
    Wallach D; Cottenot F; Bach MA
    Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):282-90. PubMed ID: 6216219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor T lymphocytes from lepromatous leprosy skin lesions.
    Modlin RL; Mehra V; Wong L; Fujimiya Y; Chang WC; Horwitz DA; Bloom BR; Rea TH; Pattengale PK
    J Immunol; 1986 Nov; 137(9):2831-4. PubMed ID: 2944966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on T cell subsets and functions in leprosy.
    Bach MA; Chatenoud L; Wallach D; Phan Dinh Tuy F; Cottenot F
    Clin Exp Immunol; 1981 Jun; 44(3):491-500. PubMed ID: 6459897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of T-cell unresponsiveness in leprosy.
    Bach MA; Hoffenbach A; Lagrange PH; Wallach D; Cottenot F
    Ann Immunol (Paris); 1983; 134D(1):75-84. PubMed ID: 6226239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
    Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR
    Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes.
    Van Voorhis WC; Kaplan G; Sarno EN; Horwitz MA; Steinman RM; Levis WR; Nogueira N; Hair LS; Gattass CR; Arrick BA; Cohn ZA
    N Engl J Med; 1982 Dec; 307(26):1593-7. PubMed ID: 6216407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor response in lepromatous leprosy patients: role of Leu 2a cells.
    del Carmen Sasiain M; de la Barrera S; Ruibal-Ares B; Cardama JE; Gatti JC; de Bracco MM
    Immunology; 1987 Jan; 60(1):13-8. PubMed ID: 2950048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.
    Modlin RL; Mehra V; Jordan R; Bloom BR; Rea TH
    J Immunol; 1986 Feb; 136(3):883-6. PubMed ID: 2416837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concanavalin A induced suppressor activity in human leprosy.
    Nath I; Narayanan RB; Mehra NK; Sharma AK; Gupte MD
    J Clin Lab Immunol; 1979 Nov; 2(4):319-24. PubMed ID: 161322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lepromin-induced suppressor cells in patients with leprosy.
    Mehra V; Mason LH; Fields JP; Bloom BR
    J Immunol; 1979 Oct; 123(4):1813-7. PubMed ID: 158056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.
    Narayanan RB; Laal S; Sharma AK; Bhutani LK; Nath I
    Clin Exp Immunol; 1984 Mar; 55(3):623-8. PubMed ID: 6423326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.